SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015472
Filing Date
2018-11-08
Accepted
2018-11-08 16:18:57
Documents
33
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 281019
2 ex31-1.htm EX-31.1 19132
3 ex31-2.htm EX-31.2 19018
4 ex32.htm EX-32 8431
  Complete submission text file 0001493152-18-015472.txt   1378460

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20180930.xml EX-101.INS 115885
6 XBRL SCHEMA FILE pvct-20180930.xsd EX-101.SCH 19139
7 XBRL CALCULATION FILE pvct-20180930_cal.xml EX-101.CAL 28786
8 XBRL DEFINITION FILE pvct-20180930_def.xml EX-101.DEF 69237
9 XBRL LABEL FILE pvct-20180930_lab.xml EX-101.LAB 146690
10 XBRL PRESENTATION FILE pvct-20180930_pre.xml EX-101.PRE 109277
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 181169933
SIC: 2834 Pharmaceutical Preparations